secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemomab Therapeutics Ltd. (CMMB)
CIK:        0001534248
Form:       8-K
Filed at:   2021-10-25T23:59:59+00:00
Accession:  0001178913-21-003237
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemomab Therapeutics files updated corporate presentation for October 2021
---------------------------------------------------------------------------

- Filed an updated corporate presentation covering its fibrotic disease pipeline.
- Presentation date is October 2021; no specific financial or clinical data disclosed in the filing.
- Presentation is furnished under Item 7.01 Regulation FD, not incorporated by reference.
- No material changes to previously disclosed information are evident from the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534248/000117891321003237/0001178913-21-003237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534248/000117891321003237/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-21-003237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer